Literature DB >> 8528198

Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus.

R Kolluri1, A Shehabeldin, M Peacocke, A M Lamhonwah, K Teichert-Kuliszewska, S M Weissman, K A Siminovitch.   

Abstract

Mutation in the gene encoding the recently isolated WASP protein has now been identified as the genetic defect responsible for the X-linked Wiskott-Aldrich syndrome (WAS), a primary immunodeficiency disease associated with extensive phenotypic variability. To elucidate the range of WASP mutations responsible for WAS, we used PCR-SSCP analysis to screen for WASP gene mutation in 19 unrelated boys with the diagnosis of classical or attenuated WAS or isolated thrombocytopenia. All 19 patients had WASP mutations, each of which localized to the initial three or terminal three exons of the gene, and the majority of which were unique in each case. However, a missense mutation which results in substitution of the arginine at WAS codon 86 was identified in three boys with severe WAS as well as in one boy presenting with thrombocytopenia alone. While the three mutations found in the isolated thrombocytopenia patients leave the reading frame intact, about one-half of the gene alterations detected in both severe and attenuated WAS patients result in frameshifted transcript and premature translation termination. These findings therefore confirm the association of WAS with WASP mutation and identify WASP mutation as a cause for isolated congenital thrombocytopenia in males. While the WASP gene defects responsible for isolated thrombocytopenia and other mild presentations of WAS do not appear distinct from those resulting in severe WAS, these data indicate that analysis of WASP gene mutation provides a valuable tool for distinguishing the spectrum of WAS patients and the subset of males with isolated thrombocytopenia who represent mild cases of WAS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8528198     DOI: 10.1093/hmg/4.7.1119

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  18 in total

Review 1.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  Management of Wiskott-Aldrich syndrome.

Authors:  A Srivastava; H A Swaid; M Kabra; I C Verma
Journal:  Indian J Pediatr       Date:  1996 Sep-Oct       Impact factor: 1.967

Review 3.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Springer Semin Immunopathol       Date:  1998

4.  N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases.

Authors:  H Miki; K Miura; T Takenawa
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

5.  Studies of the expression of the Wiskott-Aldrich syndrome protein.

Authors:  D M Stewart; S Treiber-Held; C C Kurman; F Facchetti; L D Notarangelo; D L Nelson
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

6.  Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42.

Authors:  R Kolluri; K F Tolias; C L Carpenter; F S Rosen; T Kirchhausen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

7.  Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.

Authors:  Taizo Wada; Akihiro Konno; Shepherd H Schurman; Elizabeth K Garabedian; Stacie M Anderson; Martha Kirby; David L Nelson; Fabio Candotti
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

8.  Mutations in Drosophila enabled and rescue by human vasodilator-stimulated phosphoprotein (VASP) indicate important functional roles for Ena/VASP homology domain 1 (EVH1) and EVH2 domains.

Authors:  S M Ahern-Djamali; A R Comer; C Bachmann; A S Kastenmeier; S K Reddy; M C Beckerle; U Walter; F M Hoffmann
Journal:  Mol Biol Cell       Date:  1998-08       Impact factor: 4.138

9.  Genetic and environmental risk factors for childhood eczema development and allergic sensitization in the CCAAPS cohort.

Authors:  Jocelyn M Biagini Myers; Ning Wang; Grace K LeMasters; David I Bernstein; Tolly G Epstein; Mark A Lindsey; Mark B Ericksen; Ranajit Chakraborty; Patrick H Ryan; Manuel S Villareal; Jeff W Burkle; James E Lockey; Tiina Reponen; Gurjit K Khurana Hershey
Journal:  J Invest Dermatol       Date:  2009-09-17       Impact factor: 8.551

10.  TREC and KREC profiling as a representative of thymus and bone marrow output in patients with various inborn errors of immunity.

Authors:  M Dasouki; A Jabr; G AlDakheel; F Elbadaoui; A M Alazami; B Al-Saud; R Arnaout; H Aldhekri; I Alotaibi; H Al-Mousa; A Hawwari
Journal:  Clin Exp Immunol       Date:  2020-07-21       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.